A Washington University researcher has pinpointed six biomarkers that could lead to a simple breathalyzer test for malaria.
The FDA's post-market medical device cybersecurity plans and procedures don't go far enough to protect public health in the face of cyber-threats, according to an OIG audit. The FDA, in response, has agreed with the OIG's recommendations.
The CMS is seeking input on whether it should expand Medicare coverage for blood pressure monitoring devices. Up to 55% of the Medicare population has hypertension, according to federal data.
Providers said they don't get the support they need from medical device manufacturers, and they also said they struggle with keeping accurate inventories of their devices, according to a survey by KLAS and CHIME.
MIT researchers are working on a way to target medical treatment with an 'in-body GPS.'
New technologies and devices that meld telemedicine with artificial intelligence and predictive analytics are giving hope for greater care coordination to thousands and potentially millions of people in the healthcare system.
Stryker Corp. has agreed to acquire K2M Group Holdings, a key player in the spinal medical device industry, for $1.4 billion.
Virtual reality is emerging in healthcare as a high-tech solution to problems as varied as training doctors, reducing medical errors and helping patients manage pain.
Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions. That's why today's clinical lab is more important than ever. About 13 billion diagnostic tests are performed in the U.S. each year, and nearly 70 percent of critical care decisions are driven by...
The maker of a permanent contraceptive implant subject to thousands of injury reports from women and repeated safety restrictions by regulators said Friday that it will stop selling the device in the U.S.
Abbott Laboratories needs to decide whether to jump back into the merger arena or rely on internal revenue sources to drive growth and support Abbott's shares, which have leveled off since climbing 40% to a five-year peak of $63.62 during the 12 months ended in March.
The CMS is considering covering a brain stimulation therapy device that helps treat depression in patients who don't respond to other treatments. Hospitals could receive up to $30,000 per patient if the agency covers the device.